Sangeeta N. Bhatia, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 532 shares at $386.69 ($206K) on 2025-08-27, disclosed to the SEC on 2025-08-29.
Scheduled sale ($206k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $386.69 | 266 | $103K | 50.0% |
| 2 | $386.69 | 266 | $103K | 50.0% |
| Total | $386.69 avg | 532 | $206K | 100% |
| Filing → |
| VRTX | SELL | 2025-05-05 | $202K | — | Filing → |
| VRTX | SELL | 2024-09-04 | $323K | — | Filing → |
| VRTX | SELL | 2024-08-12 | $1.2M | — | Filing → |